Skip to main content

Windlas Biotech Limited IPO Details, Price Band, GMP

 

Windlas Biotech Ltd. IPO Details


To open Demat Account Click on ZERODHA  or  UPSTOX.  

If you Open Your Demat account with Us You will
  Get Free Membership of Premium Telegram Channel.


Let’s have a detailed review of the company and analytics of the Windlas Biotech IPO release date, IPO offer price, subscription, Windlas Biotech Limited IPO allotment, Windlas Biotech grey market premium, and other details like the company’s background, financial positions of Windlas Biotech Ipo, its promoters, and other related things. 

    About Windlas Biotech Ltd. Company :-

    Windlas Biotech Limited, Incorporated in 2001 is one of the top 5 leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India in terms of revenue. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics. Company also sell its own branded products in the trade generics and OTC markets as well as export generic products to several countries.

    Currently, the focus of the company is to launch complex generic products in the chronic therapeutic category related to lifestyle-related disorders. Our complex generic products portfolio primarily comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics and chewable or dispersible, which was 68.48% in Fiscal 2021 of our total product portfolio. 

    The business operates in 3 verticals;
    1. CDMO Products and services,
    2. Domestic trade generics and Over-the-counter (OTC) market, and
    3. Export.

    We currently own and operate four manufacturing facilities located at Dehradun in Uttarakhand.

    Company have developed relationships with various leading Indian pharmaceutical companies, including Pfizer Limited, Sanofi India Limited, Cadila Healthcare Limited/ Zydus Healthcare Limited, Emcure Pharmaceuticals Limited, Eris Lifesciences Limited, Intas Pharmaceuticals Limited and Systopic Laboratories Private Limited. 
    In Fiscal 2020, we provided CDMO services to seven of the top 10 Indian formulations pharmaceutical companies

    Promoters Of Windlas Biotech Ltd. :-

    The Promoters of Company are Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt. Trust.

    Promoter Holdings :-

    Pre Issue Promoter Holdings 78%
    Post Issue Promoter Holdings65.16%

    Financials Of Windlas Biotech Ltd. :-

    ParticularsFinancials {Figs. in Millions}
    31 March 201931 March 202031 March 2021
    Total Assets2,981.803,384.882,961.23
    Total Revenue3,115.253,313.394,306.95
    Total Expenses2,841.882,992.053,871.65
    Profit After Tax638.22162.13155.70
    EPS38.618.908.70

    Financials Ratios :- 

    PE Ratio - 52.8 
    Sector PE - 

    Peers of Windlas Biotech Ltd. :-

    As per Company RHP,
    There are no listed companies in India that engage in a business similar to that of our Company. Hence, it is not possible to provide an industry comparison in relation to our Company.

    Windlas Biotech Ltd. Ipo Details :-

    IPO Opening Date4 Aug, 2021
    IPO Closing Date6 Aug, 2021
    Face Value₹5 per equity share
    IPO Price₹448 to ₹460 per equity share
    Min. Order Quantity  30 Shares
    Issue Size₹401.54 Cr
    Fresh Issue₹165 Cr
    Offer for Sale₹236.54 Cr
    Listing AtBSE NSE

    Shares Offered to :-

      QIB    50% 
    NII15%
    RII35%

    Objectives Of Ipo :-

    The net proceeds from the IPO will be utilized towards the following purposes. 
    1. To Repay of company's borrowings fully or partially.
    2. To purchase equipment required for capacity expansion of our existing facility at Dehradun Plant IV and addition of injectables dosage capability at our existing facility at Dehradun Plant-II;
    3. To finance incremental working capital requirements of the company.
    4. General corporate purposes.

    Ipo Timeline :-

    Ipo Dates 4 - 6 August 21
    Allotment Date 11 August 21
    Initiation of Refunds12 August 21
    Credit of Share to Demat Account  13 August 21
    Ipo Listing Date17 August 21

    Windlas Biotech Ipo Grey Market Premium :-

    On 4 August 2021 - Rs. 
    On 3 August 2021 - Rs. 130
    On 2 August 2021 - Rs. 150
    On 1 August 2021 - Rs. 150

    Windlas Biotech Ltd. IPO Registrar :-

    Link Intime India Private Ltd.

    Comments

    Popular posts from this blog

    What is Credit Rating Agency

      What is Credit Rating Agency Why is it Important for the Financial Business? A credit rating agency (CRA) measures the debtor’s ability to pay back the loan by making timely principal and interest payments and the possibility of default. Agencies show how strong the country and institution is financial. Three Standard & Poor, Moody’s, and Fitch names in rating world. Credit rating agencies indirectly tell how strong the country, institution, or person is financially and how much loan or loan to them is dangerous or not. That is, how much debt he has the ability to repay. It basically tells investors that a firm has a track record and shows how likely it is to be able to return the money. Currently, there are three Standard & Poor, Moody’s, and Fitch names in the rating world. They occupy about 95 percent of the market. So far, 6 credit rating agencies under SEBI, CRISIL, ICRA, CARE, SMERA, Fitch India, and Brickwork Ratings have been registered by these agencies. The rati...

    Shyam Metalics IPO Details, Ipo Date, Ipo Price, Ipo GMP

      Shyam Metalics and Energy Limited IPO Hey Guys, There are many interesting Upcoming IPOs which are scheduled to be come in 2021. One such IPO is the Shyam Metalics IPO that is going to launch on June 14, 2021. To Apply for the IPO's you should must have Demat Account.  To open  Demat Account  Click on  ZERODHA   or   UPSTOX .   If you Open Your Demat account with Us You will   Get Free Membership of Premium Telegram Channel. Let’s have a detailed review of the company and analytics of the Shyam Metalics and Energy IPO release date, IPO offer price, subscription, Shyam Metalics IPO allotment, Shyam Metalics grey market premium, and other details like the company’s background,  financial positions of Shyam Metalics , its promoters, and other related things.  About  Shyam Metalics  Company Details  :- Shyam Metalics is a leading integrated metal producing company based in India. Focusing on long steel product...

    MTAR Technologies Limited IPO Detail, price, gmp, Review

      There are many interesting IPOs which are scheduled to be launched in 2021. One such IPO is the Mtar Technologies Limited IPO that is going to launch on March 3, 2021. To Apply for the IPO's you should must have Demat Account. To open  Demat Account  Click on  ZERODHA  &  UPSTOX .   On 4 March 2021:-  GMP Rs 400 For Past trend ,See bottom of Page. MTAR Technologies is a leading national player in the precision engineering industry.  Incorporated in 1999.  The company is primarily engaged in the manufacturing of mission-critical precision components with close tolerance and in critical assemblies through its precision machining, assembly, specialized fabrication, testing, and quality control processes. Since its inception, MTAR Technologies has significantly expanded its product portfolio including critical assemblies i.e. Liquid propulsion engines to GSLV Mark III, Base Shroud Assembly & Airframes for Agni Programs, Actuat...